-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Maintains Buy on HCA Healthcare, Raises Price Target to $560

Benzinga·02/06/2026 17:22:08
Listen to the news
Argus Research analyst David Toung maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $530 to $560.